Wen-Ming Cao
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Olaparib+Trastuzumab+Pertuzumab Neoadjuvant for Elderly HER2+ Breast Cancer (NCT07695259) | Wen-Ming Cao | 2026-05-25 |
Track Wen-Ming Cao automatically
Every clearance here is in the API, with alerts when new ones post.